Skip to search formSkip to main contentSkip to account menu

Child-Pugh Classification

Known as: Child-Pugh Score 
Used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis.
2017
2017
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.
Review
2017
Review
2017
Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
Despite surgical removal of tumors with portal vein tumor thrombus (PVTT) in hepatocellular carcinoma (HCC) patients, early… 
2013
2013
Hepatocellular carcinoma in uremic patients: Is there evidence for an increased risk of mortality?
The clinical aspects of patients with hepatocellular carcinoma (HCC) undergoing maintenance dialysis are largely unknown. We… 
Review
2012
Review
2012
A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis.
2011
2011
Clinical Outcomes of Lamivudine-Adefovir Therapy in Chronic Hepatitis B Cirrhosis
Goals To determine the clinical outcome of chronic hepatitis B cirrhotics on antiviral therapy. Background The long-term outcome… 
Review
2010
Review
2010
Do chronic liver disease scoring systems predict outcomes in trauma patients with liver disease? A comparison of MELD and CTP.
BACKGROUND Although the Child-Turcotte-Pugh (CTP) score is an established outcome prediction tool for patients with liver disease… 
2009
2009
Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients
PurposeThis study evaluated the performance of the model for end-stage liver disease (MELD) in predicting post-transplant… 
2006
2006
A proposal of the modified liver damage classification for hepatocellular carcinoma.
2004
2004
Plasma and urine levels of urinary trypsin inhibitor in patients with chronic liver diseases and hepatocellular carcinoma
Background and Aim:  Because urinary trypsin inhibitor (UTI) is synthesized by hepatocytes and excreted into the urine, plasma… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)